NDC 87063-080
Liothyronine Sodium 5 ug tablet
On the label: Asclemed USA, Inc.. It's repackaged: Asclemed USA, Inc. rebottles it from SigmaPharm Laboratories, LLC's NDC 42794-018.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Sigmapharm Laboratories, LLC | Bensalem, PA, United States | Makes it and tests it | Problems found, fixed voluntarilyDec 17, 2025 · 12 inspections |
Repackaging site
- Asclemed USA Inc. dba Enovachem, Torrance, CA, United States · repackages it and relabels it
Recalls
- Apr 22, 2014 · Class II · SigmaPharm Laboratories LLC
Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.
Lots: Lot #s: a) 1302201, Exp 01/2015; 1305501, Exp 03/2015; 1314801, Exp 10/2015; b) 1302202, Exp 01/2015
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Liothyronine: every company that makes it
- Form
- tablet, oral
- Strength
- 5 ug
- Approval
- ANDA ANDA200295
- On the market since
- Dec 3, 2012
- Package NDCs
87063-080-0087063-080-0187063-080-3087063-080-6087063-080-90- Official label
- DailyMed (National Library of Medicine), updated Feb 9, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?